We carried out clearance studies in nine healthy adults and four patients with hypoparathyroidism before and after inducing stable metabolic acidosis with either NHCl or acetazolamide. Clearances were repeated in seven normal subjects and three of the patients 3 days after stopping these agents.
Introduction
A number of studies have shown that urinary calcium excretion is increased during induced (1) (2) (3) or spontaneous (4) metabolic acidosis. In the dog, acute metabolic acidosis appears to cause increased urinary calcium excretion as a result of *Submitted for publication January 5, 1967; accepted April 20, 1967. This investigation was supported in part by U. S.
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tAddress requests for reprints to Dr. Jacob Lemann, Jr., Dept. of Medicine, Marquette University School of Medicine, Milwaukee County General Hospital, 8700 West Wisconsin Ave., Milwaukee, Wis. 53226. a rise in serum filterable calcium concentration and of the filtered calcium load (5) . The mechanism of augmentation of urinary calcium excretion during sustained metabolic acidosis in man has not been elucidated.
To examine this problem, we carried out renal clearance studies in the same healthy adult subjects and in patients with hypoparathyroidism during control conditions, after stable metabolic acidosis was induced with NH4Cl .or acetazolamide, and on the 3rd recovery day after stopping these agents.
We found that urinary calcium excretion was significantly increased in the normal subjects during stable acidosis despite a significant fall in the filtered load of calcium. Augmented urinary calcium excretion persisted in the normal subjects during the recovery studies when the filtered load of calcium was at control levels. These results clearly indicate that the augmentation of urinary calcium excretion during experimental chronic metabolic acidosis in normal man is due to decreased tubular calcium reabsorption. This could not be explained by the known effects of sodium excretion (6) or the excretion of poorly reabsorbable complexing anions (7) on urinary calcium excretion. Comparable results in the patients with hypoparathyroidism, two of whom were also hypothyroid, suggest that alterations in the rates of Aecretion of parathyroid hormone or thyrocalcitonin are not the cause of the augmented urinary calcium excretion.
Methods
Studies were carried out in nine healthy adults, two patients with hypoparathyroidism, and two patients with both hypoparathyroidism and hypothyroidism. The significant clinical details concerning these patients are shown in Table I . All were receiving adequate replacement therapy when studied. All subjects were hospitalized in the Marquette University School of Medicine Clinical Research Center and received constant normal diets. All clearance studies were begun at 8:00 a.m. after overnight fasting. The subjects drank a liter of water at 7:00 a.m. to induce diuresis and thereafter were given water at intervals in amounts equivalent to urinary losses. After obtaining blood and urine samples for blank determinations, an appropriate priming dose of inulin was injected and thereafter a sustaining infusion of inulin in isotonic saline was given at 3 ml per minute with an infusion pump. After a 45-minute equilibration period, four clearance periods were collected. Blood samples were drawn at the midpoint of each period. The subjects were allowed to stand or sit to void spontaneously, but otherwise remained recumbent during the studies.
After control clearances, metabolic acidosis was induced in six of the normal subj ects and in each of the four patients by the daily oral administration of gradually increasing doses of NH4Cl for 3 to 4 days, and thereafter of a constant daily dose of NH4Cl. Clearances were repeated 7 to 11 days after NH4Cl was begun when a stable state of acidosis was present as indicated by no further fall in serum bicarbonate concentration during the 2 to 3 days before study. In the other three normal subjects, metabolic acidosis was induced by giving 250 mg of acetazolamide four times a day. In these subjects, clearances were repeated 4 to 6 days after the drug was started. Recovery clearances were carried out in seven of the normal subjects and in three of the patients on the morning of the 3rd day after stopping NH4Cl or acetazolamide. No significant symptoms occurred in any of the subjects.
Inulin in deproteinized filtrates of plasma and urine was measured with the autoanalyzer by Earley and Friedler's adaptation (8) of the method of Davidson and Sackner (9) . Serum ultrafiltrates were prepared by the method of Toribara, Terepka, and Dewey (10) . Since the quantity of calcium which is ultrafilterable varies significantly with the pH at which the ultrafiltrate is separated (10), we modified their method slightly. We handled the blood .0
Cd lu a ACIDOSIS AND CALCIUM EXCRETION specimens with anaerobic precautions and used a variety of CO2 in air mixtures for gassing the Toribara tubes, allowing a very close approximation to each subject's calculated in vivo CO2 pressure (Pco2). With these modifications, it was possible to separate the ultrafiltrate at a pH within ±0.04 U of that prevailing in vivo.
The remaining methods used in our laboratory have been described in a previous publication (11) . The results for each subject are presented as the mean of the four clearance periods in each phase of the studies. Results were evaluated by Student's t test using the equa- Table III presents the average results of the four clearance periods in each phase of the study of all normal subjects and patients. As illustrated in Table II , the agreement between replicate clearance periods was satisfactory. For all subjects, the coefficient of variation between clearance periods for those parameters required in calculating renal tubular calcium reabsorption averaged the following: inulin clearance ±9.3%o, serum ultrafilterable calcium concentration ±2.5%c, filtered calcium ±9.5%, and urinary calcium excretion ±9.8%o.
All subjects lost weight for a few days because of diuresis after NH4Cl or acetazolamide was begun and gained weight for a few days when these agents were stopped. In the control studies. the average body weight of the nine normal subjects was 63.11 ± 6.05 kg and of the four patients, 63.34 + 11.16 kg. The changes in body weight from control at the time of subsequent clearances for the normal subjects and patients averaged the following: during acidosis, -1.03 ± 1.13 kg and -1.52 ± 0.68 kg; during recovery, -0.05 ± 1.35 kg and -0.79 ± 1.03 kg, respectively. During the clearances urine flow rates were always above 8 ml per minute and were comparable in the same subject in each phase of the studies.
In Tables III, IV , and V, few important differences in the responses to acidosis produced by NH4Cl or acetazolamide in the normal subjects were noted. The differences that seem signifi-cant will be described, but otherwise the responses of all normal subjects will be considered together.
As shown in Table III , the expected rise in blood [H+] and fall in serum [HCO3-] occurred in each subject during the administration of NH4Cl or acetazolamide, and these parameters had returned to control values by the time of the recovery clearances. The severity of the acidosis was comparable between groups.
During acidosis, the serum total calcium concentration fell in eight of the nine normal subjects (d = -0.08 + 0.05 mmoles per L; p < 0.005), whereas serum ultrafilterable calcium concentration (UFca) rose in each normal subject (d = + 0.05 + 0.05 mmoles per L; p < 0.025). However, because inulin clearance was reduced during acidosis in eight of the nine normal subjects (d = -13 + 12 ml per minute; p < 0.025), the calculated rate of calcium filtration fell significantly (d =-13 + 16 pmoles per minute; p < 0.05).
Nevertheless, urinary calcium excretion (UcaV) rose in each normal subject (d = + 3.18 ± 2.01 umoles per minute; p < 0.005).
During acidosis, the patients on the average had a small increase in serum total calcium concentration, and in three of the four, UFca rose (d = + 0.10 + 0.10 mmoles per L).' The average fall in filtration rate for the patients (d = -3 + 4 ml per minute) was smaller than that noted in the normal subjects. Consequently, the calculated rate of filtration of calcium rose in two of the four patients. UcaV rose in each patient (d = + 4.63 ± 4.30 pmoles per minute). The increase in UCaV occurred despite a fall in calcium filtration rate in S. C. and M. L. and exceeded the small rise in calcium filtration rate in J. G. The striking and equivalent increases in calcium filtration rate and UcaV in L. K., who had severe idiopathic hypoparathyroidism, differed from the findings in all other subjects studied.
During the recovery clearances, UcaV remained significantly elevated above control values in the seven normal subjects (d = + 1.47 + 0.96 4moles per minute; p < 0.01) despite the return of blood acid-base measurements to normal. In four of these seven studies, because of either a persistent elevation in UFca or a rise in filtration rate, the 1 The lack of statistical significance for many of the changes observed in the patients clearly results from the small size of the group available for study. filtered load of calcium was sufficiently above control values to account for the continued increase in UcaV. In the other three normal subjects, UcaV remained above control despite a reduction in the rate of calcium filtration.
UcaV also remained elevated in the three patients studied during recovery from acidosis, despite correction of blood [H+] and serum [HCO3-] to normal. In each of these patients, the filtered load of calcium had returned to or below control levels by this time. Table IV gives the changes in UNaV, UKV, and UNH4+V during acidosis and during recovery for all studies. Serum sodium concentration remained normal and steady in all groups. Serum potassium concentration fell during acidosis and remained low during the recovery clearances in all studies. UNaV was below control rates in six of the nine normal subjects during acidosis and in all seven of the studies during recovery. There was no correlation between the variable changes in UNaV and the consistent increases in UcaV during acidosis. UKV fell in seven of the normal subjects during acidosis and in each of the seven recovery studies. As expected, UNH4+V rose significantly in each normal subject given NH4Cl, whereas smaller rises occurred in the three normal subjects made acidotic by carbonic anhydrase inhibition (acetazolamide). UNH4+V fell, but remained above control when NH4C1 administration A UCAV ,uM/min. was stopped, and exceeded the values during acidosis when acetazolamide was stopped. The changes in UNaV, UKV, and UNH4+V in the patients were comparable to those of the normal subjects given NH4Cl. Figure 1 shows a striking correlation between the increments in renal ammonium and calcium excretion above control during the acidosis and recovery clearances in the normal subjects. Figure 2 shows the same relationship in the patients with hypoparathyroidism. Table V presents the effects of induced acidosis on serum phosphorus concentration and renal phosphorus excretion. Serum phosphorus concentration fell during acidosis in six of the seven normal subjects given NH4C1 and rose slightly in each of the three normal subjects given acetazolamide. Because of the reductions in glomerular filtration rate, the filtered phosphorus load fell in seven of the nine normal subjects during acidosis. Despite this, UpV rose in all of the normal subjects. In the recovery studies in normal subjects, none of the parameters of renal phosphorus turnover differed from control observations. The results in the patients with hypoparathyroidism again closely resembled those of the normal subjects given NH4Cl.
Discussion
In the present renal clearance studies, each of nine normal subjects demonstrated an increase in 1326 Z=f= . UCaV above control rates when metabolic acidosis was induced by either increasing acid production by NH4Cl administration (six subjects) or inhibiting renal acid excretion by acetazolamide administration (three subjects). In eight of the nine normal subjects, the observed increases in UCaV occurred despite reduction in the rates of filtration of calcium. Whereas UFca rose during acidosis in each of the nine subjects, presumably because of decreased binding of calcium by serum proteins and a net increase in the rate of release of calcium from bone, inulin clearance fell to a greater extent and, thus, the calculated rate of filtration of calcium was reduced. We assume that the fall in glomerular filtration rate was due to extracellular fluid (ECF) volume depletion resulting from the initial diuretic effect of both NH4Cl and acetazolamide. Clearly, the increases in UcaV observed during acidosis in these subjects must have been due to decreased renal tubular calcium reabsorption.
UcaV remained elevated above control rates in each of the seven normal subjects studied again three days after NH4Cl or acetazolamide administration was stopped. Since blood [H+] and serum [HCO3-] had returned to control values in each subject by this time, it is clear that ECF acidosis could no longer be invoked as the cause of the augmented renal calcium excretion. However, we have shown previously (3) that during the recovery from induced metabolic acidosis blood
[H+] and serum [HCO3-] return to control levels before all of the retained acid has been eliminated from the body. Thus, it is quite conceivable that hydrogen ion concentration within cells (including those of the renal tubules) remained elevated at the time of the recovery clearances. In four of these seven recovery studies, the calculated rate of filtration of calcium had risen sufficiently to account for the persisting increase in UcaV. This occurred because of increases in inulin clearances and, in some subjects, continued slight elevation of UFea. In the remaining three studies, however, UCaV remained elevated despite rates of calcium filtration less than those of their control studies.
Although these results in normal subjects do not allow precise identification of the cause of decreased tubular calcium reabsorption during in-duced metabolic acidosis, we have considered several possibilities. Walser (6) has shown that urinary calcium excretion rises when sodium excretion is augmented. This could not account for the results of our experiments, since, on the average, urinary sodium excretion was unchanged from control values during acidosis and somewhat below control values during the recovery studies. Furthermore, there was no correlation between the variable directional changes in UNaV during acidosis and the consistent increases in UcaV. It is also unlikely that UcaV increased because of an increase in the rate of excretion of poorly reabsorbable anions capable of complexing calcium (7) . Whereas urinary phosphorus excretion was increased during acidosis, it was not elevated above control rates during the recovery clearances, when UcaV remained elevated. Urinary sulfate and organic acid excretion did not increase significantly in our earlier balance studies in which acidosis was induced in a similar manner (3) . In addition, the high urine flow rates maintained in all of the present clearance studies would have minimized, by dilution, any effects of complexing anions.
We carried out the studies in the four patients with hypoparathyroidism, two of whom were also hypothyroid, to determine whether the capacity to alter the secretion rate of parathyroid hormone, thyrocalcitonin, or both, was required for augmentation of UCaV during metabolic acidosis. We considered this possibility because the rise in ultrafilterable (and presumably ionized) calcium in the blood of the normal patients during acidosis could have altered the rates of secretion of these hormones. Parathyroid extract has been shown to augment directly calcium reabsorption at a distal tubular site in the dog (13) , and thyrocalcitonin, while not yet known to alter tubular calcium reabsorption, produces phosphaturia in the rat (14) . Since the response to metabolic acidosis in the normal subjects included both decreased tubular calcium reabsorption and decreased tubular phosphorus reabsorption, it seemed possible that these effects were mediated, respectively, by a decreased secretion of parathyroid hormone and an increased secretion of thyrocalcitonin in response to the rise in ultrafilterable (and ionized) calcium. The results in the four patients suggest that this was not the case. With the exception of the study during acidosis in patient L. K. (where the rate of calcium filtration rose sufficiently to account for the increase in UcaV), the responses of the patients closely resembled those of the normal subjects.
Finally, since metabolic acidosis alters metabolic processes in renal tubular cells in other ways (15) , it is possible that the observed decrease in calcium reabsorption during acidosis is also a direct effect on the tubule cells. A correlation between the increments in urinary ammonium and calcium excretion in response to induced acidosis was noted in both the normal subjects (Figure 1 ) and the patients (Figure 2) .
Although in two of the three normal subjects given acetazolamide maximal UcaV occurred during the acidosis clearances while UNH4+V was higher during the recovery clearances, it is known that urinary ammonium excretion may underestimate total renal tubular ammonia production during carbonic anhydrase inhibition (16) . Thus, stimulation of the metabolic processes involved in the tubular production of ammonia rather than urinary ammonium excretion per se may somehow impair renal tubular calcium reabsorption. Farquharson, Salter, Tibbetts, and Aub (1) also noted that changes in calcium and ammonium excretion were related in induced metabolic acidosis. Although they felt that calcium and ammonium excretion during acidosis were not directly interdependent, this will require further study.
